Literature DB >> 17250439

Genotype-phenotype correlation analysis in retinoblastoma patients from India.

Biju Joseph1, Rajiv Raman, Satagopan Uthra, Madhavan Jagadeesan, Anuradha Ganesh, Pradeep G Paul, Tarun Sharma, Govindasamy Kumaramanickavel.   

Abstract

BACKGROUND: Genetic analysis has a beneficial impact on retinoblastoma management enabling definite risk assessment. However, information regarding genotype-phenotype correlation in retinoblastoma is limited. AIM: To analyze the retinoblastoma susceptibility gene for mutations in retinoblastoma patients and correlate the genotypes the phenotypes.
METHODOLOGY: Eleven retinoblastoma patients, who underwent molecular genetic studies were classified into high, moderate or low disease severity groups based on phenotype.
RESULTS: Seven patients had high disease severity and four moderate disease severity. Eleven truncating mutations were detected; six were in the N-terminus region of the retinoblastoma protein and two in the A/B pocket (p=0.03).
CONCLUSIONS: No significant association between mutation type and disease severity could be established in the present study. However a positive correlation between location of the mutations in certain domains of the retinoblastoma protein and disease severity was observed. To the best of our knowledge this is the first genotype-phenotype correlation study in retinoblastoma patients from India.

Entities:  

Mesh:

Year:  2006        PMID: 17250439

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients.

Authors:  Kannan Thirumalairaj; Aloysius Abraham; Bharanidharan Devarajan; Namrata Gaikwad; Usha Kim; Veerappan Muthukkaruppan; Ayyasamy Vanniarajan
Journal:  J Hum Genet       Date:  2015-06-18       Impact factor: 3.172

2.  Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.

Authors:  Jaya Singh; Avshesh Mishra; Arunachalam Jayamuruga Pandian; Ashwin C Mallipatna; Vikas Khetan; S Sripriya; Suman Kapoor; Smita Agarwal; Satish Sankaran; Shanmukh Katragadda; Vamsi Veeramachaneni; Ramesh Hariharan; Kalyanasundaram Subramanian; Ashraf U Mannan
Journal:  Mol Vis       Date:  2016-08-16       Impact factor: 2.367

3.  Retinoblastoma genetics screening and clinical management.

Authors:  Himika Gupta; Sivasankar Malaichamy; Ashwin Mallipatna; Sakthivel Murugan; Nallathambi Jeyabalan; Vishnu Suresh Babu; Anuprita Ghosh; Arkasubhra Ghosh; Sam Santhosh; Somasekar Seshagiri; Vedam L Ramprasad; Govindasamy Kumaramanickavel
Journal:  BMC Med Genomics       Date:  2021-07-22       Impact factor: 3.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.